|
|
|
|
Orientation to Pharmacology |
|
|
1 | (1) |
|
Application of Pharmacology in Nursing Practice |
|
|
2 | (2) |
|
Drug Regulation, Development, Names, and Information |
|
|
4 | (2) |
|
II. BASIC PRINCIPLES OF PHARMACOLOGY |
|
|
|
|
|
6 | (3) |
|
|
|
9 | (2) |
|
|
|
11 | (2) |
|
Adverse Drug Reactions and Medication Errors |
|
|
13 | (2) |
|
Individual Variation in Drug Responses |
|
|
15 | (3) |
|
III. DRUG THERAPY ACROSS THE LIFESPAN |
|
|
|
Drug Therapy During Pregnancy and Breast-Feeding |
|
|
18 | (3) |
|
Drug Therapy in Pediatric Patients |
|
|
21 | (4) |
|
Drug Therapy in Geriatric Patients |
|
|
25 | (2) |
|
IV. PERIPHERAL NERVOUS SYSTEM DRUGS |
|
|
|
|
|
|
Basic Principles of Neuropharmacology |
|
|
27 | (2) |
|
Physiology of the Peripheral Nervous System |
|
|
29 | (4) |
|
|
|
|
Muscarinic Agonists and Antagonists |
|
|
33 | (5) |
|
Cholinesterase Inhibitors and Their Use in Myasthenia Gravis |
|
|
38 | (4) |
|
Neuromuscular Blocking Agents and Ganglionic Blocking Agents |
|
|
42 | (2) |
|
|
|
|
|
|
44 | (5) |
|
|
|
49 | (3) |
|
Indirect-Acting Antiadrenergic Agents |
|
|
52 | (2) |
|
V. CENTRAL NERVOUS SYSTEM DRUGS |
|
|
|
|
|
|
Introduction to Central Nervous System Pharmacology |
|
|
54 | (1) |
|
Drugs for Neurodegenerative Disorders |
|
|
|
Drugs for Parkinson's Disease |
|
|
55 | (2) |
|
|
|
57 | (2) |
|
|
|
|
|
|
59 | (4) |
|
Drugs for Muscle Spasm and Spasticity |
|
|
63 | (1) |
|
|
|
|
|
|
64 | (2) |
|
|
|
66 | (2) |
|
Opioid (Narcotic) Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics |
|
|
68 | (5) |
|
Pain Management in Patients with Cancer |
|
|
73 | (6) |
|
|
|
79 | (4) |
|
|
|
|
Antipsychotic Agents and Their Use in Schizophrenia |
|
|
83 | (2) |
|
|
|
85 | (3) |
|
Drugs for Bipolar Disorder |
|
|
88 | (2) |
|
|
|
90 | (3) |
|
Management of Anxiety Disorders |
|
|
93 | (3) |
|
Central Nervous System Stimulants and Their Use in Attention-Deficit/Hyperactivity Disorder |
|
|
96 | (2) |
|
|
|
|
Drug Abuse I: Basic Considerations |
|
|
98 | (2) |
|
|
|
100 | (2) |
|
Drug Abuse III: Major Drugs of Abuse (Other than Alcohol) |
|
|
102 | (2) |
|
VI. DRUGS THAT AFFECT FLUID AND ELECTROLYTE BALANCE |
|
|
|
|
|
104 | (4) |
|
Agents Affecting the Volume and Ion Content of Body Fluids |
|
|
108 | (3) |
|
VII. DRUGS THAT AFFECT THE HEART, BLOOD VESSELS, AND BLOOD |
|
|
|
|
|
111 | (2) |
|
Drugs Acting on the Renin-Angiotensin-Aldosterone System |
|
|
113 | (3) |
|
|
|
116 | (3) |
|
|
|
119 | (3) |
|
|
|
122 | (5) |
|
|
|
127 | (5) |
|
|
|
132 | (3) |
|
Prophylaxis of Coronary Heart Disease: Drugs That Lower LDL Cholesterol Levels |
|
|
135 | (3) |
|
Drugs for Angina Pectoris |
|
|
138 | (3) |
|
Anticoagulant, Antiplatelet, and Thrombolytic Drugs |
|
|
141 | (5) |
|
Management of Myocardial Infarction |
|
|
146 | (2) |
|
Drugs for Deficiency Anemias |
|
|
148 | (2) |
|
Hematopoietic and Thrombopoietic Growth Factors |
|
|
150 | (2) |
|
VIII. DRUGS FOR ENDOCRINE DISORDERS |
|
|
|
Drugs for Diabetes Mellitus |
|
|
152 | (5) |
|
Drugs for Thyroid Disorders |
|
|
157 | (3) |
|
Drugs Related to Hypothalamic and Pituitary Function |
|
|
160 | (4) |
|
Drugs for Disorders of the Adrenal Cortex |
|
|
164 | (2) |
|
|
|
166 | (2) |
|
|
|
|
Estrogens and Progestins and Their Use in Hormone/Replacement Therapy |
|
|
168 | (2) |
|
|
|
170 | (5) |
|
Drug Therapy of Infertility |
|
|
175 | (2) |
|
Drugs That Affect Uterine Function |
|
|
177 | (3) |
|
X. ANTI-INFLAMMATORY, ANTIALLERGIC, AND IMMUNOLOGIC DRUGS |
|
|
|
Review of the Immune System |
|
|
180 | (3) |
|
|
|
183 | (2) |
|
|
|
185 | (3) |
|
|
|
188 | (3) |
|
Cyclooxygenase Inhibitors: Nonsteroidal Anti-inflammatory Drugs and Acetaminophen |
|
|
191 | (5) |
|
Glucocorticoids in Nonendocrine Diseases |
|
|
196 | (3) |
|
XI. DRUGS FOR BONE AND JOINT DISORDERS |
|
|
|
Drug Therapy of Rheumatoid Arthritis and Gout |
|
|
199 | (4) |
|
Drugs Affecting Calcium Levels and Bone Mineralization |
|
|
203 | (5) |
|
XII. RESPIRATORY TRACT DRUGS |
|
|
|
|
|
208 | (5) |
|
Drugs for Allergic Rhinitis, Cough, and Colds |
|
|
213 | (2) |
|
XIII. GASTROINTESTINAL DRUGS |
|
|
|
Drugs for Peptic Ulcer Disease |
|
|
215 | (4) |
|
|
|
219 | (3) |
|
Other Gastrointestinal Drugs |
|
|
222 | (3) |
|
|
|
|
|
|
225 | (3) |
|
Enteral and Parenteral Nutrition |
|
|
228 | (3) |
|
|
|
231 | (3) |
|
XV. CHEMOTHERAPY OF INFECTIOUS DISEASES |
|
|
|
Basic Principles of Antimicrobial Therapy |
|
|
234 | (4) |
|
Drugs That Weaken the Bacterial Cell Wall I: Penicillins |
|
|
238 | (4) |
|
Drugs That Weaken the Bacterial Cell Wall II: Cephalosporins, Carbapenems, Aztreonam, Vancomycin, Teicoplanin, and Fosfomycin |
|
|
242 | (4) |
|
Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines, Macrolides, Clindamycin, Chloramphenicol, Linezolid, Dalfopristin/Quinupristin, and Spectinomycin |
|
|
246 | (4) |
|
Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis |
|
|
250 | (3) |
|
Sulfonamides and Trimethoprim |
|
|
253 | (3) |
|
Drug Therapy of Urinary Tract Infections |
|
|
256 | (3) |
|
Antimycobacterial Agents: Drugs for Tuberculosis, Leprosy, and Mycobacterium avium Complex Infection |
|
|
259 | (4) |
|
Miscellaneous Antibacterial Drugs: Fluoroquinolones, Metronidazole, Rifampin, Bacitracin, and Polymyxins |
|
|
263 | (2) |
|
|
|
265 | (3) |
|
Antiviral Agents I: Drugs for Non-HIV Viral Infections |
|
|
268 | (4) |
|
Antiviral Drugs II: Drugs for HIV Infection and Related Opportunistic Infections |
|
|
272 | (6) |
|
Drug Therapy of Sexually Transmitted Diseases |
|
|
278 | (2) |
|
Antiseptics and Disinfectants |
|
|
280 | (1) |
|
XVI. CHEMOTHERAPY OF PARASITIC DISEASES |
|
|
|
|
|
281 | (2) |
|
Antiprotozoal Drugs I: Antimalarial Agents |
|
|
283 | (3) |
|
Antiprotozoal Drugs II: Miscellaneous Agents |
|
|
286 | (1) |
|
|
|
287 | (2) |
|
|
|
|
Basic Principles of Cancer Chemotherapy |
|
|
289 | (3) |
|
Anticancer Drugs I: Cytotoxic Agents |
|
|
292 | (5) |
|
Anticancer Drugs II: Hormones, Hormone Antagonists, Biologic Response Modifiers, and Other Anticancer Drugs |
|
|
297 | (3) |
|
XVIII. ADDITIONAL IMPORTANT DRUGS |
|
|
|
|
|
300 | (2) |
|
|
|
302 | (3) |
|
|
|
305 | (3) |
|
Miscellaneous Noteworthy Drugs |
|
|
308 | (5) |
|
XVIX. ALTERNATIVE THERAPY |
|
|
|
|
|
313 | (3) |
|
|
|
|
|
|
316 | (3) |
|
Potential Weapons of Biologic, Radiologic, and Chemical Terrorism |
|
|
319 | |
